NCT06487598View on ClinicalTrials.gov

To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA)

NAActive, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Type 1 Diabetes
Interventions
DRUG

inj insulin to one group

One group- only inj insulin for 3 months.

DRUG

Inj Insulin with Tab Nisha-Amalaki 500 mg twice a day

second group- Inj Insulin with Tab Nisha-Dhatri 500 mg twice a day

Trial Locations (1)

411001

Hirabai Cowasji Jehangir Medical Research Institute, Pune

All Listed Sponsors
lead

Hirabai Cowasji Jehangir Medical Research Institute

OTHER

NCT06487598 - To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA) | Biotech Hunter | Biotech Hunter